Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Role of cyclin D1 amplification and expression in vulvar carcinomas.

Choschzick M, Hess S, Tennstedt P, Holst F, Bohlken H, Gieseking F, Mahner S, Woelber L, Simon R, Sauter G.

Hum Pathol. 2012 Sep;43(9):1386-93. doi: 10.1016/j.humpath.2011.11.014. Epub 2012 Mar 9.

PMID:
22406359
2.

EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome.

Woelber L, Hess S, Bohlken H, Tennstedt P, Eulenburg C, Simon R, Gieseking F, Jaenicke F, Mahner S, Choschzick M.

J Clin Pathol. 2012 Feb;65(2):133-9. doi: 10.1136/jcp-2010-079806. Epub 2011 Nov 29.

PMID:
22128196
4.
5.

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.

Elsheikh S, Green AR, Aleskandarany MA, Grainge M, Paish CE, Lambros MB, Reis-Filho JS, Ellis IO.

Breast Cancer Res Treat. 2008 May;109(2):325-35. Epub 2007 Jul 26.

PMID:
17653856
6.

Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications.

Bellacosa A, Almadori G, Cavallo S, Cadoni G, Galli J, Ferrandina G, Scambia G, Neri G.

Clin Cancer Res. 1996 Jan;2(1):175-80.

7.

CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response.

Seiler R, Thalmann GN, Rotzer D, Perren A, Fleischmann A.

Mod Pathol. 2014 Jan;27(1):87-95. doi: 10.1038/modpathol.2013.125. Epub 2013 Jul 26.

8.

Cyclin D1, EGFR, and Akt/mTOR pathway. Potential prognostic markers in localized laryngeal squamous cell carcinoma.

Dionysopoulos D, Pavlakis K, Kotoula V, Fountzilas E, Markou K, Karasmanis I, Angouridakis N, Nikolaou A, Kalogeras KT, Fountzilas G.

Strahlenther Onkol. 2013 Mar;189(3):202-14. doi: 10.1007/s00066-012-0275-0. Epub 2013 Feb 13.

PMID:
23400686
9.

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.

Reis-Filho JS, Savage K, Lambros MB, James M, Steele D, Jones RL, Dowsett M.

Mod Pathol. 2006 Jul;19(7):999-1009. Epub 2006 Apr 28.

10.

Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.

Liu SC, Zhang SY, Babb JS, Ridge JA, Klein-Szanto AJ.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):455-9.

12.
13.

Prognostic significance of cyclin D1 amplification and overexpression in oral squamous cell carcinomas.

Miyamoto R, Uzawa N, Nagaoka S, Hirata Y, Amagasa T.

Oral Oncol. 2003 Sep;39(6):610-8.

PMID:
12798405
14.

[The relationship between human papillomavirus and cyclin D1 gene amplification in squamous cell carcinomas of the head and neck].

Rodrigo Tapia JP, García González LA, Alvarez Alvarez I, Cabanillas Farpón R, Suárez Nieto C.

Acta Otorrinolaringol Esp. 2005 Nov;56(9):428-33. Spanish.

15.

The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.

Wang Z, Tropè CG, Suo Z, Trøen G, Yang G, Nesland JM, Holm R.

BMC Cancer. 2008 Oct 24;8:308. doi: 10.1186/1471-2407-8-308.

16.

PPFIA1 and CCND1 are frequently coamplified in breast cancer.

Dancau AM, Wuth L, Waschow M, Holst F, Krohn A, Choschzick M, Terracciano L, Politis S, Kurtz S, Lebeau A, Friedrichs K, Wencke K, Monni O, Simon R.

Genes Chromosomes Cancer. 2010 Jan;49(1):1-8. doi: 10.1002/gcc.20713.

PMID:
19787783
17.

Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.

Greer RO Jr, Said S, Shroyer KR, Marileila VG, Weed SA.

Oral Oncol. 2007 Sep;43(8):735-41. Epub 2006 Nov 17.

PMID:
17113340
18.
19.

Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva.

Santos M, Montagut C, Mellado B, García A, Ramón y Cajal S, Cardesa A, Puig-Tintoré LM, Ordi J.

Int J Gynecol Pathol. 2004 Jul;23(3):206-14.

PMID:
15213596
20.

Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.

Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.

Laryngoscope. 2002 Mar;112(3):472-81.

PMID:
12148857

Supplemental Content

Support Center